Clarius Group LLC Has $202,000 Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Clarius Group LLC cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 9.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,669 shares of the company’s stock after selling 291 shares during the quarter. Clarius Group LLC’s holdings in Henry Schein were worth $202,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. increased its position in Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after acquiring an additional 122 shares during the period. Aurora Investment Counsel increased its position in Henry Schein by 0.7% during the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock worth $1,533,000 after acquiring an additional 140 shares during the period. Arizona State Retirement System increased its position in Henry Schein by 0.4% during the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after acquiring an additional 149 shares during the period. Studio Investment Management LLC increased its position in Henry Schein by 3.9% during the fourth quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock worth $332,000 after acquiring an additional 155 shares during the period. Finally, Kentucky Retirement Systems Insurance Trust Fund increased its position in Henry Schein by 3.4% during the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 4,878 shares of the company’s stock worth $321,000 after acquiring an additional 161 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the transaction, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Henry Schein stock opened at $70.73 on Tuesday. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $85.39. The company has a market cap of $9.09 billion, a PE ratio of 22.45, a PEG ratio of 1.76 and a beta of 0.87. The company’s 50-day moving average is $74.73 and its two-hundred day moving average is $72.54.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the company posted $1.21 earnings per share. The business’s revenue for the quarter was down 10.5% on a year-over-year basis. Equities analysts anticipate that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on HSIC. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. SVB Leerink assumed coverage on shares of Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price on the stock. Jefferies Financial Group boosted their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. Evercore ISI boosted their target price on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research note on Wednesday, February 28th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and an average target price of $81.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.